Cenra Inc. (TPE:3716)
Taiwan · Delayed Price · Currency is TWD 35.00
-0.25 (-0.71%)
At close: Jun 25, 2026
Cenra Market Cap
Cenra has a market cap or net worth of 5.11 billion as of June 25, 2026. Its market cap has decreased by -9.30% in one year.
Market Cap
5.11B
Enterprise Value
7.30B
Revenue
8.54B
Ranking
n/a
PE Ratio
11.63
Stock Price
35.00
Market Cap Chart
Since September 2, 2024, Cenra's market cap has decreased from 6.21B to 5.11B, a decrease of -17.57%. That is a compound annual growth rate of -10.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 25, 2026 | 5.11B | 4.74% |
| Dec 31, 2025 | 4.88B | -12.15% |
| Dec 31, 2024 | 5.56B | -10.42% |
| Sep 2, 2024 | 6.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 406.93B |
| Caliway Biopharmaceuticals | 185.99B |
| Heron Neutron Medical | 60.80B |
| Pell Bio-Med Technology | 57.41B |
| LIWANLI Innovation | 5.36B |
| Steminent Biotherapeutics | 5.35B |
| Panion & Bf Biotech | 5.16B |
| SCI Pharmtech | 5.11B |